BP15062
|
Enmein
|
|
|
|
Enmein shows a significant inhibitory effect toward human tumor cell K562 with IC(50) values ranging from 3.2 μg/ml to 8.2 μg/ml.
|
BP15063
|
Epiberberine chloride
|
|
|
|
Epiberberine chloride is an alkaloid isolated from Coptis chinensis, acts as a potent AChE and BChE inhibitor, and a non-competitive BACE1 inhibitor (IC50s: 1.07, 6.03 and 8.55 μM).
|
BP15064
|
Epicatechin pentaacetate
|
|
|
|
Epicatechin pentaacetate is a phenolic compound from the V. mullaha fruit extracts, the utilization of V. mullaha fruit as functional food with prospective pharmaceutical, nutraceuticals and cosmeceutical properties.
|
BP15065
|
Ergosta-7,22-dien-3-one
|
|
|
|
Ergosta-7,22-dien-3-one shows pro-inflammatory property, it can stimulate nitric oxide production, induce the expression of genes, and induce the production of TLRs, cytokines, chemokines, and cellular adhesion molecules in J774A.1 cells.
|
BP15066
|
Esculin
|
|
|
|
Esculin is a glucoside found in horse chestnuts.
|
BP15067
|
Esonarimod
|
|
|
|
Esonarimod is an antirheumatic drug.
|
BP15068
|
Ethyl ferulate
|
|
|
|
Ethyl ferulate is the alkyl ester derivative of ferulic acid which is a naturally occurring plant product with anti-oxidative, anti-inflammatory, neuroprotective, and antiproliferative activities.
|
BP15069
|
EX-A5758
|
|
|
|
EX-A5758 is a novel putative small molecule nNOS-NOS1AP inhibitor, suppressing inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.
|
BP15070
|
Ezetimibe ketone
|
|
|
|
Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator. Ezetimibe is a potent cholesterol absorption inhibitor.Ezetimibe ketone (EZM-K) is a phase-I metabolite of Ezetimibe.
|
BP15071
|
Fenoprofen calcium dihydrate
|
|
|
|
Fenoprofen calcium is a propionic acid derivative that is used as a non-steroidal anti-inflammatory agent.
|
BP15072
|
Fiboflapon sodium
|
|
|
|
Fiboflapon sodium (GSK2190915) is an orally bioavailable 5-lipoxygenase-activating protein (FLAP) inhibitor with a potency of 2.9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood.
|
BP15073
|
Firocoxib
|
|
|
|
Firocoxib is a selective non-steroidal inhibitor of cycooxygenase-2 (COX-2) (IC50 of 0.13 μM), with anti-inflammatory for use in dogs and horses.
|
BP15074
|
Robinin
|
|
|
|
Flavone glycoside from Robinia with antibacterial and diuretic properties; derived from kaempferol.The ability of robinin to reverse the multidrug resistance of the human colon cancer cell line Colo 320 expreβing MDR1/LRP was explored by monitoring their uptake of Rhodamine 123, but was shown to have minimal effect. Robinin was detected in lysates of the human breast cancer cell line MCF-7 using liquid chromatography-tandem maβ spectrometry.
|
BP15075
|
Flavone
|
|
|
|
Flavons have effects on CYP (P450) activity which are enzymes that metabolize most drugs in the body.
|
BP15076
|
Flunixin meglumine
|
|
|
|
Flunixin Meglumin is an effective inhibitor of the enzyme cyclooxygenase with anti-inflammatory and antipyretic activity.
|
BP15077
|
2-(Phosphonooxy)benzoic acid
|
|
|
|
Fosfosal, used as the anti-inflammatory agent, has the anti-bacterial effect.
|
BP15078
|
FR 122047 hydrochloride
|
|
|
|
FR 122047 hydrochloride is a potent and selective inhibitor of COX-1 with IC50 of 28 nM and 65 µM for human recombinant COX-1 and COX-2, respectively.
|
BP15079
|
FR-188582
|
|
|
|
FR-188582 is a highly selective cyclooxygenase (COX)-2 inhibitor (IC50: 17 nM).
|
BP15080
|
Gardiquimod
|
|
|
|
Gardiquimod could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells. Gardiquimod is an imidazoquinoline analog and is a TLR7/8 agonist. When used at concentrations below 10 μM, Gardiquimod specifically activates TLR7.
|
BP15081
|
GB1107
|
|
|
|
GB1107 is an effective and selective Galectin-3 inhibitor with a Kd of 37 nM.
|